BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4558187)

  • 1. [Effect of beta-sympathicolysis on the working capacity of patients with coronary disease].
    Heck KJ; Haas W; Lang E
    Med Klin; 1972 Mar; 67(9):291-7. PubMed ID: 4558187
    [No Abstract]   [Full Text] [Related]  

  • 2. Practolol in the treatment of ischaemic heart pain. Results of a controlled trial.
    Nestel PJ
    Med J Aust; 1972 May; 1(20):1033-5. PubMed ID: 4626799
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 4. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 5. -Receptor antagonists in angina pectoris.
    Prichard BN
    Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
    Hayase S; Hirakawa S; Hosokawa S; Mori N; Kanyama S
    Arzneimittelforschung; 1972 Feb; 22(2):370-3. PubMed ID: 4554632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R; Persić T; Custović F
    Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580
    [No Abstract]   [Full Text] [Related]  

  • 8. [Data on the effects of butydrine in patients with coronary insufficiency].
    De Maestri C; Rinaldi AR
    Minerva Cardioangiol; 1969 Feb; 17(2):142-50. PubMed ID: 5777638
    [No Abstract]   [Full Text] [Related]  

  • 9. Verapamil in chronic stable angina: a controlled study with computerized multistage treadmill exercise.
    Bala Subramanian V; Lahiri A; Parmasivan R; Raftery EB
    Clin Invest Med; 1980; 3(1-2):111-8. PubMed ID: 6781805
    [No Abstract]   [Full Text] [Related]  

  • 10. [Varying response to nifedipine during treatment of stable exertional angina pectoris: results of a double-blind, randomized, cross-over, placebo-controlled study (author's transl)].
    Brügmann U; Blasini R; Goebel G; Mannes A; Dirschinger J; Rudolph W
    Herz; 1982 Apr; 7(2):117-25. PubMed ID: 7044932
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 13. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of propranolol and nitroglycerine on the electrocardiogram and the intrapulmonary pressure values during physical exercise of patients with angina pectoris].
    Roskamm H; Weidemann H; Schnellbacher K; Suplie D; Heesemann HU; Peters B; Reindell H; Blümchen G
    Dtsch Med Wochenschr; 1970 Dec; 95(52):2593-9. PubMed ID: 4992195
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 16. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol in angina pectoris.
    Zsotér TT; Beanlands DS
    Arch Intern Med; 1969 Nov; 124(5):584-7. PubMed ID: 4981284
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative exercise tolerance studies in patients with coronary insufficiency receiving practolol (author's transl)].
    Stauch M; Härich BK
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2287-92. PubMed ID: 4762829
    [No Abstract]   [Full Text] [Related]  

  • 20. A single blind trial of Trasicor (Ciba 39,089-Ba) in angina pectoris.
    Turner AS; Wilson DF
    Isr J Med Sci; 1969; 5(4):738-40. PubMed ID: 4980553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.